Study tests combo of heart valve, lower dose of blood thinners

U.S. scientists are conducting an FDA-approved study to test the safety and efficacy of using lower dosages of anti-coagulants in patients with a mechanical heart valve from On-X Life Technologies. The On-X device may become the first heart valve approved for patients taking lower doses of blood-thinning drugs and could help improve quality of life, one of the researchers said.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA